The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - MedImmune
Stock and Other Ownership Interests - MedImmune
Research Funding - MedImmune
Travel, Accommodations, Expenses - MedImmune
A phase 1, first-time-in-human study of MEDI9197, a TLR7/8 agonist, administered intratumorally in subjects with a solid tumor cancer.
 
Shilpa Gupta
Honoraria - Genentech
Consulting or Advisory Role - Genentech; Pfizer; Seagen
Speakers' Bureau - Genentech
 
Fatemeh Tavakkoli
No Relationships to Disclose
 
Serguei Soukharev
Employment - MedImmune; Sigma-Tau (I)
Travel, Accommodations, Expenses - Sigma-Tau (I)
 
Guozhi Gao
Employment - Biogen (I); MedImmune; Sanofi
Stock and Other Ownership Interests - Biogen (I); MedImmune; Sanofi
Travel, Accommodations, Expenses - MedImmune
 
Shannon R. Morris
Employment - GlaxoSmithKline; MedImmune
Stock and Other Ownership Interests - GlaxoSmithKline; MedImmune
Patents, Royalties, Other Intellectual Property - GlaxoSmithKline
 
Jeffrey S Miller
Stock and Other Ownership Interests - Fate Therapeutics
Consulting or Advisory Role - Celgene; Fate Therapeutics; Oxis International
Research Funding - Fate Therapeutics
Patents, Royalties, Other Intellectual Property - Fate Therapeutics; Oxis International Inc
Expert Testimony - NantWorks
Travel, Accommodations, Expenses - Celgene; Oxis International